EUVIMEDEUVIMED entdecken
Crossref

Construction of anti-calcification small-diameter vascular grafts using decellularized extracellular matrix/poly (L-lactide-co-ε-caprolactone) and baicalin-cathepsin S inhibitor

Yanjiao Teng, Xiaohai Zhang, Lin Song, Jianing Yang, Duo Li, Ziqi Shi, Xiaoqin Guo, Shufang Wang, Haojun Fan, Li Jiang, Shike Hou, Seeram Ramakrishna und 2 weitere

Acta Biomaterialia · 2025-05 · 197 · 184-201

DOI: 10.1016/j.actbio.2025.03.033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2025-05. Verfasst von Yanjiao Teng und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Disaster and Emergency Medicine, Tianjin University, Tianjin 300072, PR China; Key Laboratory for Disaster Medicine Technology, Tianjin 300…. Hauptthemen laut MEDLINE: Flavonoids, Blood Vessel Prosthesis, Polyesters, Decellularized Extracellular Matrix. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The long-term transplantation of small-diameter vascular grafts (SDVGs) is associated with a risk of calcification, which is a key factor limiting the clinical translation of SDVG. Hence, there is an urgency attached to the development of new SDVGs with anti-calcification properties. Here, we used decellularized extracellular matrix (dECM) and poly (L-lactide-co-ε-caprolactone) (PLCL) as base materials and combined these with baicalin, cathepsin S (Cat S) inhibitor to prepare PBC-SDVGs by electrospinning. Baicalin contains carboxyl and hydroxyl groups that can interact with chemical groups in dECM powder, potentially blocking calcium nucleation sites. Cat S inhibitor prevents elastin degradation and further reduces the risk of calcification. PBC-SDVGs were biocompatible and when implanted in rat abdominal aorta, accelerated endothelialization, enhanced vascular tissue regeneration, inhibited elastin degradation, and promoted macrophage polarization M2 phenotype to regulate inflammation. After 3 months of implantation, the results of Doppler ultrasound, MicroCT, and histological staining revealed a significant reduction in calcification. In summary, the developed anti-calcification SDVGs offer a promising strategy for long-term implantation with significant clinical application potential. STATEMENT OF SIGNIFICANCE: The dECM and PLCL were used as base materials, connected with baicalin, and loaded with Cat S inhibitor to prepare PBC-SDVGs. The baicalin and dECM powder formed hydrogen bonds to crosslink together reducing the calcium deposition. In vitro, the vascular graft downregulated the expression level of osteogenic genes and promoted macrophage polarization toward an anti-inflammatory M2 phenotype, thereby reducing calcification. The PBC-SDVGs implanted in rat abdominal aorta can accelerate endothelialization, enhance vascular tissue regeneration, inhibit elastin degradation, reduce inflammation response and calcification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonoidsBlood Vessel ProsthesisPolyestersDecellularized Extracellular MatrixVascular CalcificationAnimalsRatsMaleRats, Sprague-DawleyHumansAorta, AbdominalMacrophages

Stichwörter der Autor:innen

Anti-calcification, tissue regenerationBaicalinCathepsin S inhibitorSmall-diameter vascular grafts

Substanzen

FlavonoidsbaicalinPolyestersDecellularized Extracellular Matrixlactide-caprolactone copolymer

Autor:innen und Institutionen

  • School of Disaster and Emergency Medicine, Tianjin University, Tianjin 300072, PR China; Key Laboratory for Disaster Medicine Technology, Tianjin 300072, PR China; Wenzhou Safety (Emergency) Institute of Tianjin Univers…
  • State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210000, PR China.
  • Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, PR China.
  • Tianjin Eye Hospital, Nankai University Affiliated Eye Hospital, Tianjin 300021, PR China.
  • Department of Mechanical Engineering, College of Design and Engineering, National University of Singapore, Singapore 117575, Singapore. Electronic address: seeram@nus.edu.sg.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Teng, Y., Zhang, X., Song, L., Yang, J., Li, D., Shi, Z., Guo, X., Wang, S., Fan, H., Jiang, L., Hou, S., Ramakrishna, S., Lv, Q., & Shi, J. (2025). Construction of anti-calcification small-diameter vascular grafts using decellularized extracellular matrix/poly (L-lactide-co-ε-caprolactone) and baicalin-cathepsin S inhibitor. Acta Biomaterialia, 197, 184-201. https://doi.org/10.1016/j.actbio.2025.03.033

Vancouver

Teng Y, Zhang X, Song L, Yang J, Li D, Shi Z, et al. Construction of anti-calcification small-diameter vascular grafts using decellularized extracellular matrix/poly (L-lactide-co-ε-caprolactone) and baicalin-cathepsin S inhibitor. Acta Biomaterialia. 2025;197:184-201. doi:10.1016/j.actbio.2025.03.033

BibTeX
@article{Teng2025,
  author = {Teng, Yanjiao and Zhang, Xiaohai and Song, Lin and Yang, Jianing and Li, Duo and Shi, Ziqi and Guo, Xiaoqin and Wang, Shufang and Fan, Haojun and Jiang, Li and Hou, Shike and Ramakrishna, Seeram and Lv, Qi and Shi, Jie},
  title = {Construction of anti-calcification small-diameter vascular grafts using decellularized extracellular matrix/poly (L-lactide-co-ε-caprolactone) and baicalin-cathepsin S inhibitor},
  journal = {Acta Biomaterialia},
  year = {2025},
  volume = {197},
  pages = {184--201},
  doi = {10.1016/j.actbio.2025.03.033}
}
Kostenlos starten →